Gene Express Lung Cancer Diagnostic Demonstrates 96% Accuracy In Study

TOLEDO, OH -- Gene Express, Inc. today announced that its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study presented at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development. James C. Willey, M.D., Founder, Inventor and Chief Science and Medical Consultant to Gene Express, and his colleagues from the University of Toledo, identified a panel of 15 genes that could serve to predict cancer. According to Dr. Willey, a test for these genes, in normal cells sampled via bronchoscopy, could serve as a technique to identify those individuals genetically at risk for lung cancer. In a study of 49...